Ticker Symbol: NNVC
NanoViricides Inc
$4.80 - 20-11-2024 4 p.m. ET
Exchange: NYSE MKT LLC
Country:
US
Currency:
USD
Asset
Type: Common Stock
CIK:0001379006
Company Profile
NanoViricides, Inc. is a development stage company that is creating special purpose nanomaterials for antiviral therapy. The Company's novel nanoviricide® class of drug candidates are designed to specifically attack enveloped virus particles and to dismantle them. Its lead drug candidate is NV-HHV-101 with its first indication as dermal topical cream for the treatment of shingles rash. In addition, it is developing a clinical candidate for the treatment of COVID-19 disease caused by SARS-CoV-2 coronavirus. The Company cannot project an exact date for filing an IND for this drug because of its dependence on a number of external collaborators and consultants.
Sector: Professional, Scientific, and Technical Services
Industry: Research and Development in Biotechnology
Standard Industrial Classification Code (SIC code): 8731
Address: 1 Controls Dr
Website: www.nanoviricides.com
CEO: N/A
Tags:
- Health Technology
- Biotechnology
Pricing
Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $1.30
Change:
-$0.05
(
-3.70%)
Days Range: $1.29 - $1.37
Beta: 0.70
52wk. High: $2.00
52wk. Low: $1.04
Ytd. Change 17.92%
50 Day Moving Average: $1.30
200 Day Moving Average: $1.31
Shares Outstanding: 11746000
Valuation
Market Cap: 1.5B
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A